Santoro AN - Search Results

1

Advances in pharmacotherapies that target the cell cycle for treatment of breast cancer: where are we at today?

Perrone M, Giuliani F, Sanna V, Bruno S, Melaccio A, Santoro AN, Laface C, Maselli FM, Iaia ML, Guarini C, Fancellu A, Fedele P. Perrone M, et al. Among authors: santoro an. Expert Opin Pharmacother. 2023 Jun;24(8):887-900. doi: 10.1080/14656566.2023.2201373. Epub 2023 Apr 12. Expert Opin Pharmacother. 2023. PMID: 37038927 Review.

2

Immunotherapy in Prostate Cancer: State of Art and New Therapeutic Perspectives.

Maselli FM, Giuliani F, Laface C, Perrone M, Melaccio A, De Santis P, Santoro AN, Guarini C, Iaia ML, Fedele P. Maselli FM, et al. Among authors: santoro an. Curr Oncol. 2023 Jun 13;30(6):5769-5794. doi: 10.3390/curroncol30060432. Curr Oncol. 2023. PMID: 37366915 Free PMC article. Review.

3

The Treatment Landscape of Elderly Patients with Hormone Receptor-Positive Her2 Negative Advanced Breast Cancer: Current Perspectives and Future Directions.

Laface C, Giuliani F, Melaccio A, Pappagallo MN, Santoro AN, Perrone M, De Santis P, Guarini C, Carrozzo D, Fedele P. Laface C, et al. Among authors: santoro an. J Clin Med. 2023 Sep 16;12(18):6012. doi: 10.3390/jcm12186012. J Clin Med. 2023. PMID: 37762952 Free PMC article. Review.

4

Antibody-Drug Conjugates in HR+ Breast Cancer: Where Are We Now and Where Are We Heading?

De Santis P, Sanna V, Perrone M, Guarini C, Santoro AN, Laface C, Carrozzo D, Oliva GR, Fancellu A, Fedele P. De Santis P, et al. Among authors: santoro an. J Clin Med. 2023 Nov 26;12(23):7325. doi: 10.3390/jcm12237325. J Clin Med. 2023. PMID: 38068376 Free PMC article. Review.

5

[No title available]

[No authors listed] [No authors listed] PMID: 35643643

6

Early-stage triple negative breast cancer: the therapeutic role of immunotherapy and the prognostic value of pathological complete response.

De Santis P, Perrone M, Guarini C, Santoro AN, Laface C, Carrozzo D, Oliva GR, Fedele P. De Santis P, et al. Among authors: santoro an. Explor Target Antitumor Ther. 2024;5(1):232-250. doi: 10.37349/etat.2024.00215. Epub 2024 Feb 28. Explor Target Antitumor Ther. 2024. PMID: 38464390 Free PMC article. Review.

7

Immunotherapy and Pancreatic Cancer: A Lost Challenge?

Laface C, Memeo R, Maselli FM, Santoro AN, Iaia ML, Ambrogio F, Laterza M, Cazzato G, Guarini C, De Santis P, Perrone M, Fedele P. Laface C, et al. Among authors: santoro an. Life (Basel). 2023 Jun 30;13(7):1482. doi: 10.3390/life13071482. Life (Basel). 2023. PMID: 37511856 Free PMC article. Review.

8

The Resistance to EGFR-TKIs in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Clinical Application of New Therapeutic Strategies.

Laface C, Maselli FM, Santoro AN, Iaia ML, Ambrogio F, Laterza M, Guarini C, De Santis P, Perrone M, Fedele P. Laface C, et al. Among authors: santoro an. Pharmaceutics. 2023 May 27;15(6):1604. doi: 10.3390/pharmaceutics15061604. Pharmaceutics. 2023. PMID: 37376053 Free PMC article. Review.

9

Edmonton Symptom Assessment Scale may reduce medical visits in patients undergoing chemotherapy for breast cancer.

Sanna V, Fedele P, Deiana G, Alicicco MG, Ninniri C, Santoro AN, Pazzola A, Fancellu A. Sanna V, et al. Among authors: santoro an. World J Clin Oncol. 2022 Jul 24;13(7):577-586. doi: 10.5306/wjco.v13.i7.577. World J Clin Oncol. 2022. PMID: 36157162 Free PMC article.

10

Tailoring antiHer2 treatment strategies in breast cancer and beyond.

Fedele P, Sanna V, Santoro AN, Iaia ML, Fancellu A. Fedele P, et al. Among authors: santoro an. Curr Probl Cancer. 2022 Oct;46(5):100892. doi: 10.1016/j.currproblcancer.2022.100892. Epub 2022 Aug 11. Curr Probl Cancer. 2022. PMID: 36055059 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page